Highest-materiality recent filing
NVE CEO Baker retires; Eames named president and CEO at annual meeting
Daniel A. Baker retired as president/CEO effective Aug 6, 2026; reelected to board and elected chairman.
NVE Corp Q1 revenue up 81% to $11.0M, EPS $1.32 vs $0.74, declares $1.00 dividend
Revenue $11.0M (+81% YoY); product sales +82%, contract R&D +53%.
NVE CEO Daniel Baker to retire Aug 6, 2026; Peter Eames named successor; board expands to 7
CEO Daniel Baker retires effective Aug 6, 2026; will remain Chairman if shareholders approve.
NVE Q4 revenue up 5% to $7.65M, EPS $1.02; declares $1.00 dividend
Q4 revenue $7.65M (+5% YoY); product sales up 6%, contract R&D down 19%.
NVE reports Q3 revenue up 23% to $6.22M, EPS $0.70 (+11% YoY); declares $1.00 dividend
Q3 total revenue $6.22M, up 23% from $5.06M; product sales +16%, contract R&D +335%.
NVE extends Abbott supply agreement through 2027 with pricing increases for 2026-2027
Amendment No. 12 to Supplier Partnering Agreement with Pacesetter (Abbott) executed Dec 12, 2025.
NVE Q2 revenue down 6% to $6.35M; EPS $0.68 vs $0.83; declares $1.00 dividend
Total revenue $6.35M, down 6% YoY; product sales +1%, contract R&D -68%.
All five director nominees elected: Glarner, Baker, Hollister, Bracke, Wei each received >2.98M votes with minimal withhold.
NVE Q1 revenue down 10% to $6.10M; EPS $0.74 vs $0.85; declares $1.00 dividend
Revenue $6.10M (down 10% YoY), net income $3.58M (down 13%); diluted EPS $0.74.
NVE Q4 revenue up 3% to $7.27M, EPS $0.80; full-year revenue down 13%; $1.00 dividend declared
Q4 revenue $7.27M (+3% YoY); net income $3.89M ($0.80 EPS) vs $3.81M ($0.79).
Amendment No. 11 extends Supplier Partnering Agreement term to December 31, 2025.
NVE Q3 revenue down 25% to $5.06M, net income falls 27% to $0.63 EPS; $1.00 dividend declared
Q3 total revenue $5.06M, down 25% YoY; product sales fell 22% and contract R&D revenue dropped 74%.
NVE extends office/manufacturing lease to May 2031 with escalating rent
Lease extended 62 months, new expiration May 31, 2031 (originally March 31, 2026).
NVE Q2 revenue down 5% to $6.76M; EPS $0.83 vs $0.98; declares $1.00 dividend
Total revenue for Q2 FY2025: $6.76M, down 5% from $7.13M; product sales fell 14%, contract R&D surged 3,950%.
NVE shareholders elect all five directors, approve say-on-pay, ratify auditor
All five director nominees elected: Glarner (2.78M for), Baker (3.06M), Hollister (2.85M), Bracke (3.05M), Wei (3.06M).
NVE reports Q1 revenue down 23% to $6.78M, EPS $0.85 vs $0.91 prior year
Total revenue $6.78M, down 23% YoY; product sales fell 24%, contract R&D up 28%.
NVE director Richard Kramp dies; Dr. Kelly Wei elected to board
Director Richard W. Kramp passed away May 2, 2024 after an illness; served on NVE board since 2014.
NVE Q4 revenue $7.08M (-45%), EPS $0.79; FY revenue $29.8M (-22%); declares $1.00 dividend
Q4 revenue $7.08M (-45% YoY); net income $3.81M ($0.79 EPS) down 54%.
NVE Q3 revenue down 9% to $6.76M; net income down 1% to $4.18M; declares $1/share dividend
Total revenue for quarter ended Dec 31, 2023: $6.76M, down 9% vs $7.40M prior year. Product sales down 12%; contract R&D up 94%.
NVE extends Abbott supply pact through Dec 2024 with price increases
Amendment No. 10 extends Supplier Partnering Agreement with Abbott subsidiary Pacesetter through December 31, 2024.
NVE Q2 revenue falls 33% to $7.13M; EPS drops to $0.98 from $1.26; $1.00 dividend declared
Total revenue for Q2 FY2024 was $7.13M, down 33% from $10.7M YoY; product sales down 32%, contract R&D down 92%.
NVE Corp amends bylaws for majority voting; shareholders reelect directors and approve proposals
Bylaws amended to require majority vote in uncontested director elections, replacing plurality standard.
NVE Corp amends 2015 supply agreement with Sonova AG on pricing, payment terms, lead time
Second Amendment to 2015 Supply Agreement with Sonova AG effective July 17, 2023.
NVE Q1 revenue up 20% to $8.83M, net income up 6%, declares $1.00 dividend
Total revenue $8.83M for June quarter, up 20% YoY; product sales up 23%.
NVE Corp CFO Joseph Schmitz resigns; Daniel Nelson named Principal Financial Officer
Joseph R. Schmitz resigned as CFO effective May 5, 2023.
NVE Corp Q4 rev +91% to $12.8M, EPS $1.70; FY net income record $22.7M; declares $1.00 dividend
Q4 total revenue $12.8M, up 91% YoY; net income $8.23M ($1.70 diluted EPS), up 116%.
NVE extends Abbott supplier pact to Dec 2023, raises prices on three parts
Amendment No. 9 extends the Supplier Partnering Agreement through Dec 31, 2023; prior term had expired.
NVE Q3 rev $7.4M (+18% YoY), EPS $0.88 (+22%); declares $1.00/share dividend
Q3 total revenue increased 18% to $7.40M; product sales up 22% YoY.
NVE reports Q2 revenue up 57% to $10.7M, EPS $1.26 vs $0.75
Total revenue for Q2 FY2023 increased 57% to $10.7M from $6.82M.
NVE shareholders elect all five directors and approve executive pay at 2022 annual meeting
Elected directors: Terrence W. Glarner (3,066,755 for, 389,986 withheld), Daniel A. Baker, Patricia M. Hollister, Richard W. Kramp, James W. Bracke.
NVE Q1 FY2023 revenue up 3% to $7.34M; net income +16% to $0.86 diluted EPS
Revenue $7.34M (+3% YoY); net income $4.14M ($0.86 EPS) vs $3.58M ($0.74 EPS) in prior-year quarter.
NVE Q4 revenue up 15% to $6.72M; EPS $0.79 vs $0.65 YoY; declares $1.00 dividend
Q4 total revenue $6.72M (+15% YoY); product sales +12%, contract R&D +104%.
NVE extends Abbott supplier agreement through Dec 2022; pricing amended
Executed Amendment No. 8 to Supplier Partnering Agreement with Abbott on Feb 1, 2022.
NVE Q3 revenue down 4% to $6.29M; EPS $0.72 vs $0.81; declares $1.00 dividend
Q3 total revenue $6.29M, down 4% YoY; product sales down 7%, contract R&D up 86%.
NVE appoints Joseph R. Schmitz as CFO effective January 20, 2022
Joseph R. Schmitz, age 59, appointed CFO; previously management roles at Trane Technologies.
NVE Corporate Controller and PFO Jon Larson resigns effective Jan 3; CEO Baker interim
Jon J. Larson resigned as Corporate Controller and Principal Financial Officer, effective January 3, 2022.
NVE reports Q2 revenue up 56% to $6.82M; EPS $0.75 vs $0.46; declares $1.00 dividend
Q2 total revenue $6.82M (+56% YoY); net income $3.65M (+64%); diluted EPS $0.75 vs $0.46.
NVE CFO Curt Reynders retires Oct 1; Jon Larson appointed Principal Financial Officer
Curt A. Reynders retired as CFO on October 1, 2021, as previously disclosed in July.
NVE annual meeting elects new director James W. Bracke; all proposals pass
Gary R. Maharaj did not stand for reelection, term expired Aug 5, 2021; James W. Bracke elected to board.
NVE reports Q1 revenue $7.15M (+56%), EPS $0.74; CFO to retire; $1 dividend
Total revenue $7.15M, up 56% YoY; product sales up 60% to $6.95M.
On June 22, 2026, NVE Corporation (the “Company”) announced that Daniel A. Baker, Ph.D., age 68, will retire as President and Chief Executive Officer effective at the Company’s Annual Shareholders’ meeting on August 6, 2026.
Current Chairman Terence W. Glarner, age 83, was nominated to remain on the Board.
The Board of Directors appointed Peter G. Eames, age 50, currently serving as Vice President of Advanced Technology, as President and Chief Executive Officer effective at that time.
Additionally, the Board nominated Caroyln W. Valentine to its Board of Directors.
the NVE Board of Directors elected Kelly Wei, Ph.D. to join the Board effective May 13, 2024.
Director Richard W. Kramp passed away on May 2, 2024.
Daniel Nelson has been appointed Accounting Manager and Principal Financial Officer.
Effective May 5, 2023, Joseph R. Schmitz resigned as Chief Financial Officer
On January 17, 2022, our Board of Directors appointed Joseph R. Schmitz as our Chief Financial Officer effective January 20, 2022.
President and Chief Executive Officer Daniel A. Baker has been appointed interim Principal Financial Officer.
Jon J. Larson resigned as NVE’s Corporate Controller and Principal Financial Officer effective January 3, 2022 .
Effective with Mr. Reynder’s retirement, our Board of Directors appointed our Corporate Controller, Jon J. Larson, as our Principal Financial Officer effective October 1, 2021.
Max materiality 0.90 · Median 0.60 · Most common event earnings